Efficacy of Haemophilus influenzae type b vaccination of children: A meta-analysis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 25, Issue 2, 2006, Pages 90-97

  Obonyo, C O ^a,b   Lau, J ^c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Department of Ophthalmology   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE VACCINE; PLACEBO;

BACTERIAL PNEUMONIA; CLINICAL TRIAL; COCHRANE LIBRARY; CRYING; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EMBASE; FEEDING DISORDER; FEVER; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HYPOTONIC HYPORESPONSIVE EPISODE; IRRITABILITY; LOCAL SKIN REACTION; MEDLINE; MENINGITIS; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; VACCINATION;

CHILD, PRESCHOOL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HUMANS; INFANT; ODDS RATIO; SENSITIVITY AND SPECIFICITY; VACCINES, CONJUGATE;

EID: 33644695618     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-006-0092-4     Document Type: Review

References (38)

1. Peltola H (2000) Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 13:302-317
2. World Health Organization (1998) Global program for vaccines and immunization. The WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 73:64-68
3. Bijlmer HA (1991) Worldwide epidemiology of Haemophilus influenzae meningitis; industrialized versus non-industrialized countries. Vaccine 9(Suppl 1):S5-S9
4. Granoff DM, Munson RS (1986) The prospects of prevention of Haemophilus influenzae type b disease by immunization. J Infect Dis 153:448-461
5. Force RW, Lugo RA, Nahata MC (1992) Haemophilus influenzae type b conjugate vaccines. Ann Pharmacother 26:1426-1440
6. Adams WG, Deaver KA, Cochi SL, Pilkaytis BD, Zell ER, Broome CV, Wenger JD (1993) Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 269:221-226
7. Murphy TV, White KE, Pastor P, Gabriel L, Medley F, Granoff DM, Osterholm MT (1993) Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA 269:246-248
8. Watt JP, Levine OS, Santosham M (2003) Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, AZ, 22-25 September 2002. J Pediatr 143 (Suppl 6):S163-S187
9. Juni B, Altman DG, Egger M (2001) Systematic reviews of healthcare: assessing the quality of controlled clinical trials. BMJ 323:42-46
10. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
11. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558
12. DeMets DL (1987) Methods for combining randomized clinical trials: strengths and limitations. Stat Med 6:314-350
13. Eskola J, Kayhty H, Takala AK, Peltola H, Ronnberg P-R, Kela E, Pekkanen E, McVerry PH, Makela PH (1990) A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med 323:1381-1387
14. Ward J, Brenneman G, Letson GW, Heyward WL; The Alaska H. influenzae Vaccine Study Group (1990) Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaskan native infants. N Engl J Med 323:1393-1401
15. Black SB, Shinefield HR, Fireman B, Hiatt R, Polen M, Vittinghoff E; The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group (1991) Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae b (HBOC) vaccine in a United States population of 61 080 children. Pediatr Infect Dis J 10:97-104
16. Santosham M, Wolff M, Reid R, Hohenboken M, Bateman M, Goepp J, Cortese M, Sack D, Hill J, Newcomer W, Capriotti L, Smith J, Owen M, Gahagan S, Hu D, Kling R, Lukacks L, Ellis RW, Vella PP, Calandra G, Matthews H, Ahonkhai V (1991) The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 324:1767-1772
17. Vadheim CM, Greenberg DP, Patridge S, Jing J, Ward J; Kaiser-UCLA Vaccine Study Group (1993) Effectiveness and safety of an Haemophilus influenzae type B conjugate vaccine (PRP-T) in young infants. Pediatrics 92:272-279
18. Booy R et al (1994) Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 344:362-366
19. Lagos R, Horwitz I, Toro J, Martin OS, Abrego P, Bustamante C, Wasserman SS, Levine OS, Levine MM (1996) Large-scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 15:216-222
20. Mulholland K, Hilton S, Adegbola K, Usen S, Oparaugo A, Omosigho C, Weber M, Palmer A, Schneider G, Jobe K, Lahai G, Jaffar S, Secka O, Lin K, Ethevenaux C, Greenwood B (1997) Randomised trial of Haemophilus influenzae type b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 349:1191-1197
21. Shapiro ED, Wald ER (1990) Protective efficacy of PRP-D conjugate vaccine against Haemophilus influenzae type b. In: Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, Georgia, October 1990, Abstract no. 604. American Society for Microbiology, Washington District of Columbia
22. Osterholm MT, Jacobs JL, White KE (1990) Efficacy of Haemophilus influenzae b plain polysaccharide vaccine and conjugate vaccine in Minnesota. In: Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, Georgia, October 1990, Abstract no. 449A. American Society for Microbiology, Washington District of Columbia
23. Barbour ML, Mayon-White R, Coles C, Crook DWM, Moxon R (1995) The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 171:193-198
24. Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM (1993) Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 122:517-523
25. Takala AK, Santosham M, Almeido-Hill J, Wolff M, Newcomer W, Reid R, Kayhty H, Esko E, Makela PH (1993) Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccines reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J 12:593-599
26. Mohle-Boetani JC, Ajello G, Breneman E, Deaver KA, Harvey C, Plikaytis BD, Farley MM, Stephens DS, Wenger JD (1993) Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J 12:589-593
27. Adegbola RA, Mulholland EK, Secko O, Jaffar S, Greenwood BM (1998) Vaccination with Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among Gambian children. J Infect Dis 177:1758-1761
28. Peltola H, Kilpi T, Antila M (1992) Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines. Lancet 340:592-594
29. Adegbola RA, Usen SO, Weber M, Lloyd-Evans N, Jobe K, Mulholland K, McAdam KP, Greenwood BM, Milligan PJ (1999) Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine. Lancet 354:1091-1092
30. Van Alphen L, Spanjaard L, van der Ende A, Dankert J (1995) Absence of meningitis caused by Haemophilus influenzae type b in the Netherlands following twofold vaccination. Ned Tijdschr Geneeskd 139:880-884
31. Adegbola RA, Secka O, Lohai G, Lloyd-Evans N, Njie A, Usen S, Oluwalana C, Obaro S, Weber M, Corrah T, Mulholland K, McAdam K, Greenwood B, Milligan PJM (2005) Elimination of Haemophilus influenzae type b disease from The Gambia after the introduction of routine immunization with a Hib conjugate vaccine: a prospective study. Lancet 366:144-150
32. Garpenholt O, Hugosson S, Fredlund H, Bodin L, Olcen P (1999) Epiglottitis in Sweden before and after introduction of vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J 18:490-493
33. Keyser JS, Derkay CS (1994) Haemophilus influenzae type b epiglottitis after immunization with HbOC conjugate vaccine. Am J Otolayngol 15:436-443
34. Takala AK, Peltola H, Eskola J (1994) Disappearance of epiglottitis during large-scale vaccination with Haemophilus influenzae type b conjugate vaccine among children in Finland. Laryngoscope 104:731-735
35. Levine OS, Ortiz E, Contreras R, Lagos R, Vial P, Misraji A, Ferreccio C, Espinoza C, Adlerstein L, Herrera P, Casar C (1993) Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile. Am J Epidemiol 137:1221-1228
36. Hussey GD, Lasser ML, Reekie WD (1995) The costs and benefits of a vaccination programme for Haemophilus influenzae type b disease. S Afr Med J 85:20-25
37. Miller MA (1998) An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia. Pediatr Infect Dis J 9(Suppl 1):246-252
38. Madhi SA, Petersen K, Khoosal M, Huebner RE, Mbelle N, Mothupi R, Salooie H, Crewe-Brown H, Klugman KP (2002) Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 21:315-321